HARROW, INC. (Nasdaq:HROW)

Health Care/Life Sciences • Pharmaceuticals

CIK 1360214

Company

Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding segment focuses on the operations of the ImprimisRx business. The company was founded by Mark L. Baum and Robert J. Kammer in January 2006 and is headquartered in Nashville, TN.

Address
102 Woodmont Boulevard
Suite 610
Nashville, Tennessee 37205

Employees
315

Stock Info

Close
$26.25

Day Range
25.19 - 26.30

52 Week Range
9.30 - 59.23

Average volume
341.26K

Short Interest
2.73M (02/14/25)

% of Float Shorted
8.87%

Market Cap
$934.89M

Revenue
$130.19M

Net Income
-$24.41M

2020 Sales Growth
N/A

Rev. per Employee
N/A

P/E Ratio
N/A

EPS
-$0.94

Yield
N/A

Dividend
N/A

Ex-Dividend Date
N/A

Key Executives

Board Of Directors

Chairman & Chief Executive Officer
Mark L. Baum

Independent Director
Adrienne L. Graves

Independent Director
Lauren P. Silvernail

Lead Independent Director
Perry J. Sternberg

SEC filings

Date	Form	Event
5 Dec, 2024	SC 13G/A
14 Nov, 2024	8-K
14 Nov, 2024	10-Q
28 Oct, 2024	8-K
8 Oct, 2024	SC 13G/A
13 Sep, 2024	4
9 Sep, 2024	8-K
7 Aug, 2024	10-Q
7 Aug, 2024	8-K
26 Jun, 2024	8-K
17 Jun, 2024	8-K
17 Jun, 2024	4
17 Jun, 2024	4
17 Jun, 2024	4
17 Jun, 2024	4
13 May, 2024	10-Q
13 May, 2024	8-K
30 Apr, 2024	SC 13D/A
26 Apr, 2024	DEFA14A
26 Apr, 2024	DEF 14A
25 Apr, 2024	4
24 Apr, 2024	4
19 Apr, 2024	4
28 Mar, 2024	4
25 Mar, 2024	4
22 Mar, 2024	4
21 Mar, 2024	8-K
20 Mar, 2024	8-K
19 Mar, 2024	10-K
19 Mar, 2024	8-K
6 Mar, 2024	4
21 Feb, 2024	4
21 Feb, 2024	4
21 Feb, 2024	4
15 Feb, 2024	8-K
13 Feb, 2024	SC 13G/A
13 Feb, 2024	SC 13G
9 Feb, 2024	SC 13G/A
8 Feb, 2024	4
8 Feb, 2024	4
30 Jan, 2024	3
30 Jan, 2024	4
30 Jan, 2024	4
30 Jan, 2024	3
29 Jan, 2024	SC 13G
29 Jan, 2024	8-K
9 Jan, 2024	SC 13G
3 Jan, 2024	8-K	CEO Change
24 Nov, 2023	SC 13G
16 Nov, 2023	4
16 Nov, 2023	4
14 Nov, 2023	4
13 Nov, 2023	10-Q
13 Nov, 2023	8-K
3 Nov, 2023	8-K
29 Sep, 2023	8-K
20 Sep, 2023	4
18 Aug, 2023	SC 13D/A
15 Aug, 2023	4
15 Aug, 2023	4
9 Aug, 2023	8-K
9 Aug, 2023	10-Q
21 Jul, 2023	8-K
20 Jul, 2023	4
20 Jul, 2023	4
20 Jul, 2023	4
19 Jul, 2023	424B5
18 Jul, 2023	8-K
18 Jul, 2023	424B5
23 Jun, 2023	4
23 Jun, 2023	4
23 Jun, 2023	8-K
23 Jun, 2023	4
23 Jun, 2023	4
11 May, 2023	10-Q
11 May, 2023	8-K
28 Apr, 2023	DEF 14A
28 Apr, 2023	DEFA14A
4 Apr, 2023	4
4 Apr, 2023	4
4 Apr, 2023	4
28 Mar, 2023	8-K
23 Mar, 2023	10-K
23 Mar, 2023	8-K
23 Jan, 2023	8-K
20 Jan, 2023	SC 13G/A
12 Jan, 2023	8-K
3 Jan, 2023	4
3 Jan, 2023	4
23 Dec, 2022	4
23 Dec, 2022	4
23 Dec, 2022	4
23 Dec, 2022	4
21 Dec, 2022	CERT
20 Dec, 2022	8-A12B
20 Dec, 2022	8-K
19 Dec, 2022	424B5
16 Dec, 2022	305B2
16 Dec, 2022	FWP
16 Dec, 2022	8-K
14 Dec, 2022	424B5
14 Dec, 2022	8-K
14 Dec, 2022	8-K
14 Dec, 2022	4
14 Dec, 2022	424B5
14 Nov, 2022	10-Q
14 Nov, 2022	8-K
11 Oct, 2022	8-K
5 Oct, 2022	8-K
3 Oct, 2022	4
30 Sep, 2022	4
22 Sep, 2022	8-K
9 Aug, 2022	10-Q
9 Aug, 2022	8-K
13 Jun, 2022	8-K
10 Jun, 2022	4
10 Jun, 2022	4
10 Jun, 2022	4
10 Jun, 2022	4
10 Jun, 2022	4
6 Jun, 2022	EFFECT
1 Jun, 2022	UPLOAD
1 Jun, 2022	CORRESP
26 May, 2022	S-3
26 Apr, 2022	DEF 14A
26 Apr, 2022	DEFA14A
13 Apr, 2022	4
13 Apr, 2022	8-K
8 Apr, 2022	3
8 Apr, 2022	3
31 Mar, 2022	8-K
10 Mar, 2022	8-K
10 Mar, 2022	10-K
23 Feb, 2022	4
23 Feb, 2022	4
14 Feb, 2022	SC 13G
10 Feb, 2022	SC 13G/A
31 Jan, 2022	4
28 Jan, 2022	SC 13D/A
26 Jan, 2022	SC 13G/A
21 Jan, 2022	4
10 Jan, 2022	8-K
20 Dec, 2021	8-K
9 Dec, 2021	8-K
9 Nov, 2021	8-K
9 Nov, 2021	8-K
9 Nov, 2021	10-Q
27 Sep, 2021	4
17 Sep, 2021	4
14 Sep, 2021	EFFECT
10 Sep, 2021	UPLOAD
10 Sep, 2021	CORRESP
3 Sep, 2021	S-3
2 Sep, 2021	8-K
23 Aug, 2021	8-K
23 Aug, 2021	4
19 Aug, 2021	4
18 Aug, 2021	8-K
10 Aug, 2021	10-Q
10 Aug, 2021	8-K
10 Aug, 2021	8-K
27 Jul, 2021	8-K
23 Jul, 2021	4
23 Jul, 2021	4
23 Jul, 2021	4
22 Jul, 2021	4
21 Jul, 2021	8-K
12 Jul, 2021	SC 13G/A
28 Jun, 2021	4
28 Jun, 2021	4
28 Jun, 2021	4
28 Jun, 2021	4
25 Jun, 2021	S-8
22 Jun, 2021	4
17 Jun, 2021	8-K
15 Jun, 2021	424B5
14 Jun, 2021	FWP
14 Jun, 2021	424B5
14 Jun, 2021	8-K
7 Jun, 2021	8-K
21 May, 2021	4
19 May, 2021	DEFA14A
14 May, 2021	D
11 May, 2021	10-Q
11 May, 2021	8-K
6 May, 2021	CERT
5 May, 2021	8-K
27 Apr, 2021	4
27 Apr, 2021	4
27 Apr, 2021	SC 13D/A
23 Apr, 2021	DEF 14A
23 Apr, 2021	DEFA14A
20 Apr, 2021	8-A12B
20 Apr, 2021	8-K
16 Apr, 2021	305B2
16 Apr, 2021	424B5
15 Apr, 2021	FWP
14 Apr, 2021	424B5
14 Apr, 2021	8-K
12 Apr, 2021	4
12 Apr, 2021	8-K
8 Apr, 2021	8-K
5 Apr, 2021	8-K
23 Mar, 2021	SEC STAFF
8 Mar, 2021	8-K
8 Mar, 2021	8-K
8 Mar, 2021	10-K
26 Feb, 2021	4
26 Feb, 2021	4
23 Feb, 2021	4
23 Feb, 2021	SEC STAFF
23 Feb, 2021	4
23 Feb, 2021	4
12 Feb, 2021	SC 13G/A
10 Feb, 2021	SC 13G
9 Feb, 2021	8-K
4 Feb, 2021	8-K
2 Feb, 2021	SC 13G
27 Jan, 2021	8-K
21 Jan, 2021	8-K

Last update:2025-03-06 12:10:26.600359

Sign Up to Subscribe

Interested in special situations?

Join Tickerverse

customize event filters
create watchlists, bookmarks
get email notifications for the latest special situations
browse and analyze public companies, executives and SEC filings

Tickerverse is a great way to find investment opportunities in corporate actions.

By signing up you agree to our Terms of Service and Privacy Policy.